Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Diffusion in the Membrane01:24

Protein Diffusion in the Membrane

6.2K
Proteins show rotational as well as lateral diffusion across the membrane. The lateral diffusion of proteins was confirmed through the cell fusion experiment where mouse and human cells were fused, resulting in hybrid cells. When the human and mouse cells fused, the specific membrane proteins on human and mouse cells were marked with the red and green-fluorescent markers, respectively. Initially, the red and green fluorescence was located on the respective hemisphere of the cell. As time...
6.2K
Conserved Binding Sites01:49

Conserved Binding Sites

5.3K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.3K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

15.6K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
15.6K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

5.4K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
5.4K
Ligand Binding Sites02:40

Ligand Binding Sites

15.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The emerging portrait of GDNF: A small neuroinductive isoform named djGDNF47.

International journal of biological macromolecules·2025
Same author

In Silico Born Designed Anti-EGFR Aptamer Gol1 Has Anti-Proliferative Potential for Patient Glioblastoma Cells.

International journal of molecular sciences·2025
Same author

Long-Range Electrostatics in Serine Proteases: Machine Learning-Driven Reaction Sampling Yields Insights for Enzyme Design.

Journal of chemical information and modeling·2025
Same author

Dynamic interchange between two protonation states is characteristic of active sites of cholinesterases.

Protein science : a publication of the Protein Society·2024
Same author

Modern non-polarizable force fields diverge in modeling the enzyme-substrate complex of a canonical serine protease.

Physical chemistry chemical physics : PCCP·2023
Same author

Challenges in Protein QM/MM Simulations with Intra-Backbone Link Atoms.

Journal of chemical information and modeling·2023

Related Experiment Video

Updated: Apr 5, 2026

Identifying the Binding Proteins of Small Ligands with the Differential Radial Capillary Action of Ligand Assay DRaCALA
09:26

Identifying the Binding Proteins of Small Ligands with the Differential Radial Capillary Action of Ligand Assay DRaCALA

Published on: March 19, 2021

4.1K

Leveraging Auxiliary Potentials in RFDiffusion for the Design of NA-Binding Proteins.

Elizaveta Geraseva1,2, Grigoriy Bokov3, Vladimir Polovnikov3

  • 1AI Research Center, Lomonosov Moscow State University, 119991 Moscow, Russia.

Journal of Chemical Information and Modeling
|April 3, 2026
PubMed
Summary

Designing nucleic acid-binding proteins is challenging. Combining computational strategies like px0-guided potentials and rigid-body averaging improves protein design, balancing interface quality with foldability for better nucleic acid-binding protein development.

More Related Videos

Fluorescence Anisotropy as a Tool to Study Protein-protein Interactions
10:44

Fluorescence Anisotropy as a Tool to Study Protein-protein Interactions

Published on: October 21, 2016

31.9K
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.7K

Related Experiment Videos

Last Updated: Apr 5, 2026

Identifying the Binding Proteins of Small Ligands with the Differential Radial Capillary Action of Ligand Assay DRaCALA
09:26

Identifying the Binding Proteins of Small Ligands with the Differential Radial Capillary Action of Ligand Assay DRaCALA

Published on: March 19, 2021

4.1K
Fluorescence Anisotropy as a Tool to Study Protein-protein Interactions
10:44

Fluorescence Anisotropy as a Tool to Study Protein-protein Interactions

Published on: October 21, 2016

31.9K
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.7K

Area of Science:

  • Computational biology
  • Protein design
  • Nucleic acid-protein interactions

Background:

  • Designing de novo nucleic acid-binding proteins is complex due to target size and electrostatics.
  • Existing platforms like RFDiffusion require refined strategies for nucleic acid target design.
  • Two main design paradigms, de novo generation and motif-scaffolding, are explored.

Purpose of the Study:

  • To systematically investigate and compare de novo generation and motif-scaffolding strategies for nucleic acid-binding protein design.
  • To evaluate enhancements to standard design frameworks, including rigid-body-averaged and px0-guided potentials.
  • To assess the impact of these strategies on interface quality, foldability, and target specificity.

Main Methods:

  • Systematic comparison of de novo generation and motif-scaffolding across 11 diverse nucleic acid targets.
  • Evaluation of rigid-body-averaged potential and px0-guided potential enhancements.
  • Assessment of protein foldability using Boltz2 and computational metrics.

Main Results:

  • The px0-guided potential yields favorable interfaces but compromises foldability.
  • Rigid-body averaging alone improves refolding coherence without direct interface gains.
  • Combining px0 and averaging strategies balances interface metrics and computational foldability.
  • Motif-scaffolding performance is context-dependent, with auxiliary potentials showing variable success.
  • Newer models may produce superficially good metrics but lack specificity and diversity.

Conclusions:

  • Modular, tunable potentials, especially when combined, offer advantages over monolithic approaches for nucleic acid-binding protein design.
  • The study provides a practical comparative assessment to guide future de novo design efforts.
  • Balancing interface optimization with foldability is crucial for successful nucleic acid-binding protein design.